ALDH1A1, a recognized diagnostic target overexpressed in bladder cancer, and its downstream target TUBB3 can be degraded to reduce invasion and proliferation, providing new avenues for diagnosis and therapy in advanced disease [34,35]. This evidence concerns the gene ALDH1A1 and urinary bladder carcinoma.